Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors
- PMID: 19184590
- DOI: 10.1007/978-3-540-87895-7_8
Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors
Abstract
Okadaic acid is functionally a potent tumor promoter working through inhibition of protein phosphatases 1 and 2A (PP1 and PP2A), resulting in sustained phosphorylation of proteins in cells. The mechanism of tumor promotion with okadaic acid is thus completely different from that of the classic tumor promoter phorbol ester. Other potent inhibitors of PP1 and PP2A - such as dinophysistoxin-1, calyculins A-H, microcystin-LR and its derivatives, and nodularin - were isolated from marine organisms, and their structural features including the crystal structure of the PP1-inhibitor complex, tumor promoting activities, and biochemical and biological effects, are here reviewed. The compounds induced tumor promoting activity in three different organs, including mouse skin, rat glandular stomach and rat liver, initiated with three different carcinogens. The results indicate that inhibition of PP1 and PP2A is a general mechanism of tumor promotion applicable to various organs. This study supports the concept of endogenous tumor promoters in human cancer development.
Similar articles
-
Tumor promoters--microcystin-LR, nodularin and TNF-α and human cancer development.Anticancer Agents Med Chem. 2011 Jan;11(1):4-18. doi: 10.2174/187152011794941163. Anticancer Agents Med Chem. 2011. PMID: 21269254 Review.
-
The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers.J Cancer Res Clin Oncol. 2018 Dec;144(12):2339-2349. doi: 10.1007/s00432-018-2765-7. Epub 2018 Oct 20. J Cancer Res Clin Oncol. 2018. PMID: 30341686 Free PMC article. Review.
-
Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin.Cancer Res. 1993 Mar 1;53(5):1012-6. Cancer Res. 1993. PMID: 8439947
-
Mechanisms of action of okadaic acid class tumor promoters on mouse skin.Environ Health Perspect. 1991 Jun;93:211-4. doi: 10.1289/ehp.9193211. Environ Health Perspect. 1991. PMID: 1663450 Free PMC article.
-
Corozalic acid: a key okadaic acid biosynthetic precursor with phosphatase inhibition activity.Chemistry. 2010 Oct 11;16(38):11576-9. doi: 10.1002/chem.201001327. Epub 2010 Aug 27. Chemistry. 2010. PMID: 20803584
Cited by
-
Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality.J Transl Med. 2023 May 11;21(1):317. doi: 10.1186/s12967-023-04145-z. J Transl Med. 2023. PMID: 37170215 Free PMC article.
-
Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription.J Biol Chem. 2014 Aug 15;289(33):22723-22738. doi: 10.1074/jbc.M114.575050. Epub 2014 Jun 16. J Biol Chem. 2014. PMID: 24936058 Free PMC article.
-
LincR-PPP2R5C Deficiency Alleviates Airway Remodeling by Inhibiting Epithelial-Mesenchymal Transition Through the PP2A/TGF-β1 Signaling Pathway in Chronic Experimental Allergic Asthma.Allergy Asthma Immunol Res. 2024 Jul;16(4):422-433. doi: 10.4168/aair.2024.16.4.422. Allergy Asthma Immunol Res. 2024. PMID: 39155740 Free PMC article.
-
Effect of okadaic acid on cultured clam heart cells: involvement of MAPkinase pathways.Biol Open. 2012 Dec 15;1(12):1192-9. doi: 10.1242/bio.20122170. Epub 2012 Sep 25. Biol Open. 2012. PMID: 23259053 Free PMC article.
-
LincR-PPP2R5C Promotes Th2 Cell Differentiation Through PPP2R5C/PP2A by Forming an RNA-DNA Triplex in Allergic Asthma.Allergy Asthma Immunol Res. 2024 Jan;16(1):71-90. doi: 10.4168/aair.2024.16.1.71. Allergy Asthma Immunol Res. 2024. PMID: 38262392 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources